Pfizer for Ages 5-11 Approved


Commonwealth Media Services: Nat

Covid-19 vaccine being put into a hypodermic needle.

On Friday, October 29, 2021, the FDA approved the emergency use of both doses of Pfizer & BioNTech for children ages five through eleven. The lengthy expected approval from the FDA came after the organization’s Vaccines and Related Biological Products Advisory Committee decided to make a lesser dose of the Pfizer & BioNTech vaccine available to younger children. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee for Immunization Practices have also met up about this situation on the week of November 2, 2021. They have agreed on the administration of the shots.

The recommended dosage for ages 5 to 11 is 10mcg/ 0.2mL, regardless of the subject’s size or weight. This is a third of the normal dosage administered to ages twelve and older, and the shots must be received three weeks apart from each other. At this time, however, only Pfizer & BioNTech is approved for the age range. If the child turns twelve between their first and second dose, having previously received the 10mcg Pfizer shot, then the second dose administered to them will be the 30mcg Pfizer vaccine. Booster doses, however, are not recommended for ages 5 through 11 at this time. 

Tests on the Pfizer vaccine for ages 5-11 included more than 4,600 members, run by the FDA and CDC’s safety surveillance organizations. Pfizer Inc. has been updating its safety monitoring as well. Even though there is an increase in the risk of developing Myocarditis, the inflammation of the heart’s muscles, and Pericarditis, the inflammation of the tissue surrounding the heart, the FDA’s studies determine that the vaccine’s benefits greatly outweigh all risks associated with getting the vaccine, as well as coming in contact with the Covid-19 virus.

Some common side effects of the vaccine are pain, redness, and swelling at the injection site, fatigue, headache, muscle pain, chills, and fever, to name a few. These side effects were more common after receiving the second dose and usually went away two days prior to vaccination. The Pfizer & BioNTech vaccine’s recorded effectiveness for 5-11-year-olds is demonstrated to be 90.7% against the Covid-19virus, as well as against preventing symptomatic infections.  

Always contact a doctor if unsure if the qualifications imposed are met or if any questions on the ages 5-11 Pfizer vaccine are present.